Article
MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies.
Clinical chemistry - 7 Feb 2024
Blewett Timothy, Rhoades Justin, Liu Ruolin, Xiong Kan, Sridhar Sainetra, Crnjac Andjela, Cheng Ju, Lawless Aleigha R, Frederick Dennie T, Flaherty Keith T, Makrigiorgos Gerassimos Mike, Adalsteinsson Viktor A
Abstract excerpt
BACKGROUND: Tracing patient-specific tumor mutations in cell-free DNA (cfDNA) for minimal residual disease (MRD) detection is promising but challenging. Assaying more mutations and cfDNA stands to improve MRD detection but requires highly accurate, efficient sequencing methods and proper calibration to prevent false detection with bespoke tests. METHODS: MAESTRO (Minor Allele Enriched Sequencing Through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
